Trending

Tourette Syndrome Treatment Market Size | In-depth Segmentation | Future Scenario

Increasing drug approval by regulatory authorities is projected to foster the growth of the Tourette syndrome treatment market. For instance, in October 2017, Neurocrine Biosciences Inc. announced that the Food Drug and Administration approved valbenazine orphan drug designation to treat pediatric patients with Tourette syndrome. Also, a growing partnership among key players for developing new treatments is again augmenting the growth of the market.

For instance, in September 2017, Teva Pharmaceutical Industries and Nuvelution Pharma announced their partnership to develop AUSTEDO (deutetrabenazine) tablets for the treatment of tics which is associated with tourette syndrome in pediatric patients in the U.S. This partnership will drive the development of Austedo (deutetrabenazine) in Tourette syndrome by bringing new treatment options more quickly which are more necessary for the affected young patients.

Ask for PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2642

In March 2019, Wesley Medical Research partnered with the University of Sydney in Australia which carried the clinical trial to investigate whether medical cannabis could be used to treat individuals with Tourette syndrome. This trial will help examine the efficacy and safety of cannabinoids on tic frequency as well as the psychiatric symptoms associated with Tourette syndrome.

In August 2019, Emalex Biosciences, Inc. (Emalex), announced that it has received Fast Track designation for its investigational product, ecopipam, from the U.S. Food and Drug Administration (FDA) for the treatment of patients with Tourette Syndrome (TS)

Tourette syndrome (TDS), otherwise known as vocal nodules, is composed of the symptoms and signs of Tourette syndrome, which are repetitive and rapid speech patterns, tics, and other unique characteristics which can be different in each individual. The most common sign of Tourette syndrome is tics, which are unexpected, repetitive, jaw-dropping, or yelp-like sounds that some individuals make. A person with Tourette disorder has multiple vocal tics and at times even has multiple motor tics. The person can also have problems with balance and gait and tend to twirl, jig, and skip. Treatments include muscle relaxation exercises, speech therapy, neurofeedback, biofeedback, vitamin and mineral supplementation, psychotherapy, and sometimes medication

Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2642

Top Key Players:

Neurocrine Biosciences Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Apotex, Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals Limited and Eli Lilly Pharmaceuticals.

Tourette Syndrome Treatment Market Segmentation

On the basis of drug class:

  • Antiadrenergic Agents
  • Antipsychotic Agents
  • Atypical Antipsychotics
  • Carbonic Anhydrase Inhibitor Anticonvulsants
  • Others

On the basis of distribution channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/2642

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note – In order to provide more accurate Market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702

nirav

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformation growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Back to top button